SCHEMBL17656309

SCHEMBL17656309

O=C(O)CNCC(=O)NCC(=O)c1ccc(Br)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 2/20 0.46
PARP1 P09874 2/20 0.46
HAO1 Q9UJM8 1/20 0.45
ALDH1A1 P00352 2/20 0.44
MAPT P10636 2/20 0.44
GAA P10253 1/20 0.44
HDAC1 Q13547 3/20 0.44
HDAC8 Q9BY41 3/20 0.44
HDAC3 O15379 1/20 0.43
HDAC4 P56524 1/20 0.43
HDAC7 Q8WUI4 1/20 0.43
HDAC2 Q92769 1/20 0.43
HDAC10 Q969S8 1/20 0.43
HDAC11 Q96DB2 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43
HDAC9 Q9UKV0 1/20 0.43
HDAC5 Q9UQL6 1/20 0.43
POLB P06746 2/20 0.41
CYP3A4 P08684 1/20 0.41
CA1 P00915 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9977220 0.83 HDAC1 (0.54) GSK3BPARP1HAO1ALDH1A1MAPT
SCHEMBL2708907 0.80 SDCBP (0.51) PARP1ALDH1A1CA1CA2KMT2A
SCHEMBL203074 0.80 SDCBP (0.51) PARP1ALDH1A1CA1CA2KMT2A
SCHEMBL10187752 0.79 GSK3B (0.55) GSK3BHAO1ALDH1A1MAPTGAA
SCHEMBL11071677 0.79 KMT2A (0.54) GSK3BHAO1ALDH1A1MAPTHDAC1
SCHEMBL5640455 0.78 GSK3B (0.50) GSK3BPARP1HAO1ALDH1A1MAPT
SCHEMBL11558787 0.76 HAO1 (0.54) GSK3BHAO1ALDH1A1MAPTGAA
SCHEMBL7963547 0.75 GSK3B (0.55) GSK3BHAO1ALDH1A1MAPTGAA
SCHEMBL20245203 0.75 HDAC1 (0.49) GSK3BPARP1ALDH1A1MAPTHDAC1
SCHEMBL17656310 0.75 TAS1R3 (0.41) PARP1ALDH1A1MAPTGAAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3002281-B1 ANTIVIRAL COMPOUNDS GILEAD PHARMASSET LLC (US) 2017-09-13 EP disclosed
EP-3002281-A1 ANTIVIRAL COMPOUNDS Gilead Pharmasset LLC (US) 2016-04-06 EP disclosed